<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Safwaan H. Khan</title>
  <link rel="stylesheet" href="style.css" />
</head>
<body>
  <header>
    <div class="container">
      <h1>Safwaan H. Khan</h1>
      <p>Ph.D. Student – Pharmaceutical Sciences & Pharmacogenomics @ UCSF</p>
      <p><a href="mailto:safwaan.khan@ucsf.edu">safwaan.khan@ucsf.edu</a> | 510-673-1541</p>
    </div>
  </header>

  <main class="container">
    <section>
      <h2>Education</h2>
      <ul>
        <li><strong>UCSF</strong> – Ph.D. in PSPG (2024–Present), GPA: 4.00</li>
        <li><strong>UCLA</strong> – B.S. in Biochemistry (2021–2024), GPA: 3.98</li>
      </ul>
    </section>

    <section>
      <h2>Research Experience</h2>
      <ul>
        <li>
          <strong>Eyquem Lab, UCSF</strong> (2025–)<br>
          Engineered CAR-T therapies against solid tumor antigens. Designed and cloned AAV vectors.
        </li>
        <li>
          <strong>Okada Lab, UCSF</strong> (2024)<br>
          Studied hypoxic glioblastoma regions; identified splice epitope upregulation via bioinformatics.
        </li>
        <li>
          <strong>Owen Witte Lab, UCLA</strong> (2022–2024)<br>
          Developed TCRs for PAP. Isolated MHC complexes for MS. Engineered nanobody-antibody constructs.
        </li>
        <li>
          <strong>Loes Loohuis Lab, UCLA</strong> (2021–2023)<br>
          Helped build Latin American biobank; coordinated neurobehavioral data collection.
        </li>
      </ul>
    </section>

    <section>
      <h2>Industry Experience</h2>
      <ul>
        <li><strong>CooperVision</strong> – Clinical Research Intern (2022)<br>
          Co-authored clinical development plans and designed a study tracker system.
        </li>
      </ul>
    </section>

    <section>
      <h2>Publications & Presentations</h2>
      <ul>
        <li><em>Khan SH</em> et al. (2025). Advances in CAR T Cell Therapy. <strong>Front Immunol</strong>.</li>
        <li>SPUR Oral Presentation: CAR T Cell Therapy and Prostate Cancer. UCLA, 2023.</li>
      </ul>
    </section>

    <section>
      <h2>Awards & Honors</h2>
      <ul>
        <li>Magna Cum Laude, UCLA (2024)</li>
        <li>Departmental Highest Honors, UCLA (2024)</li>
        <li>UCLA URC Research Scholar (2023)</li>
        <li>Van Trees Endowment Award (2023)</li>
        <li>National Merit Scholar (2021)</li>
      </ul>
    </section>
  </main>

  <footer>
    <div class="container">
      <p>© 2025 Safwaan H. Khan</p>
    </div>
  </footer>
</body>
</html>
